The largest database of trusted experimental protocols

5 protocols using stat3

1

Autophagy Modulation in Cancer Therapeutics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Metformin (D150959), CQ (C6628), MDC (30432), 3-MA (M9281), 4',6-diamidino-2- phenylindole (DAPI; D9542), antibodies against anti-β and LC3, anti-rabbit secondary antibody, anti-mouse secondary antibody and Cy3-labeled rabbit secondary antibody were purchased from Sigma (St. Louis, MO, USA). Antibodies against p-Stat3 (Y705), Stat3, cyclin D1, LC3, PCNA and PARP were purchased from Cell Signaling (Beverly, MA, USA); antibodies against p-AMPK, p-mTOR, Beclin-1, Bcl-2, p62 and Bax were purchased from Santa Cruz (Santa Cruz, CA, USA). Anti-phospho-Histone H3 (Ser10) antibody was purchased from Upstate (Millipore, Billerica, MA, USA). Dulbecco's modified Eagle's medium (DMEM) and fetal bovine serum were obtained from Gibco (Life Technologies Gibco/BRL, New York, NY, USA). Crystal violet staining and JC-1 were obtained from Beyotime Institute of Biotechnology (Shanghai, China). ApopTag plus peroxidase in situ apoptosis detection kit was obtained from Millipore. AO was obtained from Poly-Sciences (Warrington, PA, USA). Stat3, AMPK, Beclin-1 and Atg5 siRNAs were purchased from Shanghai GenePharma (Shanghai, China). Lipofectamine 2000 was bought from Invitrogen (Carlsbad, CA, USA).
+ Open protocol
+ Expand
2

Transfection of Autophagy Regulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
The siRNAs to Atg5, Beclin-1, Stat3, AMPK or control siRNA were all purchased from Shanghai GenePharma. Cells were transfected with siRNA using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Cells were incubated for 48 h before further treatment.
+ Open protocol
+ Expand
3

Silencing Survivin and STAT3 in GBM Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were transfected twice with the same siRNA at a 24-h interval with lipofectamine 2000 (Invitrogen). The final concentration of siRNAs was 20 nM. Sequences for the siRNAs used were the following: survivin, 5′-GCATTCGTCCGGTTGCGCT-3′; STAT3, 5′-GUUCAUCUGUGUGACACCATT-3′; nontargeting siRNA controls, 5′-UUCUCCGAACGUGUCACGUTT-3′ (Genepharma, Shanghai, China). The STAT3 cDNA (KIAA1524) was purchased from the Addgene plasmid repository (http://www.addgene.org/). After transfection, U251 and U87 cells were cultured in the presence of G418 (0.8 mg/mL) for 8 weeks to select for stable transfectants. GBM cells that stably expressed STAT3 were used for treatment with YM155 and radiation.
+ Open protocol
+ Expand
4

siRNA Synthesis for STAT3 Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
SMARTpool small interfering RNAs (siRNA), including control and STAT3 were synthesized by Shanghai GenePharma Co. (Shanghai, China). The procedure has been described previously [29 (link)].
+ Open protocol
+ Expand
5

Modulating α5-nAChR Expression in Lung Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
siRNAs for CHRNA5 (encoding α5‐nAChR), Jab1, Stat3 and the negative control were obtained from GenePharma. Transient transfection of A549 and H1299 cells was performed using the Oligofectamine 2000 (Invitrogen) protocol and 5‐nmol siRNAs in RPMI supplemented with 10% FBS and no penicillin or streptomycin as described previously.18 Human CHRNA5 cDNA was subcloned into a pGV‐puro lentiviral vector containing the puromycin resistance to establish stable A549 and H1299 (Genechem) cell lines to induce α5‐nAChR overexpression (marked as α5‐nAChR+). Stable A549 and H1299 cells were selected by incubating cells in medium supplemented with puromycin for 48 hours after transfection.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!